Playing Catch-Up: Mylan And Biocon To Team Up On Generic Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. generics giant and Indian biotech hope their collaboration will position them against Teva/Lonza, Sandoz, and other potential competitors.